Treatment of hypoglycemia due to a rare pathogenic variant in with waxy maize heat-modified starch.

Key Clinical Message: The gain-of-function c.49G>A variant causes hypoketotic hypoglycemia with variable associated features. Due to lack of effective medications, treatment is primarily supportive.